Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE

Sponsor
The Hong Kong Polytechnic University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06000865
Collaborator
University of Waterloo (Other), The University of Hong Kong (Other), University of Leicester (Other)
56
2
16

Study Details

Study Description

Brief Summary

Falls are one of the most serious public health concerns for seniors, with significant medical and economic consequences. This concern is even higher in patients with peripheral field loss due to glaucoma because of the patients' compromised visual input. The investigators' project proposes an innovative, entertaining, easily accessible and enjoyable intervention for improving mobility and postural control function in glaucoma patients with peripheral vision loss, who are more prone to falls and suffer from fear of falling. The new intervention examined in this project can be implemented in current vision and balance rehabilitation programs, and may benefit patients with different types of visual impairment to minimize their risk of falls and improve their quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Action video game training
  • Behavioral: Conventional physical training
N/A

Detailed Description

A prospective, 2-arm, randomized, single-blind, active-control trial will enroll 56 moderately- to severely-affected glaucoma patients with stable peripheral field loss, intact cognitive function, and no history of balance training. Participants will be randomly assigned 1:1 to one of two groups: 1) standing, physically interactive action video-game training (AVG_PI); and 2) conventional physical training (PT). AVG using a Nintendo Switch gaming station will be administered in 20 sessions over 10 weeks (45 minutes per session, 2 sessions per week). Participants in the AVG_PI will be in standing position with game controllers or sensors attached to the body while playing games involving muscle stretching and strengthening exercises. Participants in the PT will receive 45-minutes conventional physical training. Outcome measures will be assessed before training, and after 10 and 20 training sessions. The primary outcome measure is a test of mobility, and the secondary outcome measures include tests for dynamic balance plus visual cognition, static balance, visual cognition, and patient reported outcomes for fear of falling and quality of life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
The GRADE Randomized Trial: Glaucoma Rehabilitation With Action viDeo Games and Exercise
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Dec 10, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Interactive action video-game training (AVG)

AVG using a Nintendo Switch gaming station will be administered in 20 sessions over 10 weeks (45 minutes per session, 2 sessions per week). Participants will be in standing position with game controllers or sensors attached to the body while playing games involving muscle stretching and strengthening exercises.

Behavioral: Action video game training
20 sessions of AVG over 10 weeks (45 minutes per session, 2 sessions per week)

Experimental: Conventional physical training (PT)

Participants in the PT will receive 45-minutes conventional physical training.

Behavioral: Conventional physical training
20 sessions of physical training over 10 weeks (45 minutes per session, 2 sessions per week)

Outcome Measures

Primary Outcome Measures

  1. Gait Measure - Time Up and Go test combining Narrow path walking test [Change from baseline at week 5 and change from baseline at week 10.]

    Time Up and Go test combining Narrow path walking test: All participants need to stand up from a 46 cm height chair, walk on the path at their usual pace until the strip of a non-reflective tape, cross over the tape, turn 180°, walk to the starting position and finally sit down. Then repeat the same procedure within a narrower width. Participants need to use the dominant leg to step onto the standing position on one force plate while the non-dominant leg stands on the other force plate. The test will repeat for 10 times. Participants' gait parameters including hip flexion/extension (degree), knee Min/Max (degree), ankle flexion/extension (degree), walking speed (mm/s), step width (mm), and step length(mm) will be measured and analyzed for each condition.

Secondary Outcome Measures

  1. Static Balance Measure [Change from baseline at week 5 and change from baseline at week 10.]

    Static Balance: Participants will be asked to stand on a force place with a foam while performing visual searching. Parameters including maximum antero-posterior amplitude (mm), maximum medio-lateral amplitude (mm), total sway path (mm), and root mean square sway (mm/s) will be analyzed. Each test would be repeated for 3 times.

  2. Perturbed Balance Measure [Change from baseline at week 5 and change from baseline at week 10.]

    Perturbed Balance: Participants will be asked to stand on a force place which will translate forward or backward while performing visual searching. Parameters including latency (ms) reacting to the perturbation, maximum antero-posterior amplitude (mm), maximum medio-lateral amplitude (mm), total sway path (mm), and root mean square sway (mm/s) will be analyzed. Each test would be repeated for 3 times.

  3. Useful field of view (UFOV) [Change from baseline at week 5 and change from baseline at week 10.]

    Visual attention will be examined by Useful Field of View (UFOV). Participants will be asked to complete the following 3 tasks. Processing speed: Participants will be asked to discriminate the central presented stimulus as a target or distractor. Divided attention: In addition to discriminating the central target, participants are required to identify the location of the peripheral target. Selective attention: Procedure is similar as "Divided attention". Participants are required to identify the location of peripheral target among the distractors. Parameter includes time to reach threshold(ms)

  4. Reaction time (RT) [Change from baseline at week 5 and change from baseline at week 10.]

    Each participant is asked to complete the following task using a customized computer programme. Reaction Time Test: Participants will be asked to respond as fast as possible when the same stimulus (an 'x' emerging in a square in the middle of the screen) was presented. This test will be repeated for 3 blocks with 46 trials per block. Parameter includes reaction time to correct answer(ms).

  5. Cognitive Reflection Test [Change from baseline at week 5 and change from baseline at week 10.]

    Each participant is asked to complete the following task using a customized computer programme. Cognitive Reflection Test: Participants will be presented with four squares horizontally on the screen. They will be asked to react to an 'x' emerging in one of the squares (40 trials in total) by pressing a corresponding key on a keyboard-'1', '2', '3', or '4' which present the position of 'x' . Parameter includes reaction time to correct answer(ms).

  6. Quality of Life Questionnaire measure [Change from baseline at week 5 and change from baseline at week 10.]

    The effect of intervention on quality of life will be evaluated using the Learning Vector Quantization (LvQ) Scale. In the LvQ, participants will be asked to rate how much their eyesight has interfered with each of 24 activities in the past month. The completion results in a summed score between 0 (a low quality of life) and 125 (a high quality of life).

  7. Fear of Falling Questionnaire measure [Change from baseline at week 5 and change from baseline at week 10.]

    The effect of intervention on fear of falling will be evaluated using the Chinese versions of Falls Efficacy Scale International (FES-I). In the FES-I, participants will be asked "how concerned they are about the possibility of falling" for each of the 16 social and physical activities. The completion results in a summed score between minimum 16 (no concern about falling) to maximum 64 (severe concern about falling).

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Presence of moderate to severe bilateral glaucomatous optic neuropathy (GON) from primary open-angle (including normal tension) or angle-closure glaucoma, as determined by an ophthalmologist, with abnormal Glaucoma Hemifield Test on standard Humphrey Field Analyzer 24-2 testing and matching nerve-fiber layer thinning on optical coherence tomography;

  2. Stable vision and visual field loss for at least 3 months;

  3. With a best-corrected distance acuity of 6/12 or better (equivalent to 0.3 logMAR acuity or better to confirm that participant's central vision is preserved);

  4. With a cognitive functional score of 22 or above in the Montreal Cognitive Assessment

  • Hong Kong version (to confirm participants' intact cognitive function).
Exclusion Criteria:
  1. Advanced glaucoma with GON of median deviation worse than -25 decibel;

  2. Ocular diseases other than glaucoma (e.g., age-related macular degeneration, diabetic retinopathy, and moderate to severe cataract);

  3. Severe medical problems (e.g., stroke, Parkinson's disease) or self-reported neurological (e.g. brain surgery, brain tumor and peripheral neuropathy), or cognitive disorders (e.g., diagnosed dementia or cognitive impairment);

  4. Physical impairments (e.g. need the use of orthopedic and mobility aids) or physical limitations restricting them from independent walking;

  5. Self-reported or medically diagnosed vestibular/ cerebellar dysfunction, history of vertigo, or severe hearing loss;

  6. Using any medications for any neurological conditions or psychiatric drugs (e.g. sedative, hypnotic) that might interfere motor control; and

  7. Currently attending any intensive physical/balance training.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Hong Kong Polytechnic University
  • University of Waterloo
  • The University of Hong Kong
  • University of Leicester

Investigators

  • Principal Investigator: Allen Cheong, PhD, The Hong Kong Polytechnic University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Allen MY Cheong, Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT06000865
Other Study ID Numbers:
  • 15602821
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Allen MY Cheong, Professor, The Hong Kong Polytechnic University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023